Biotransformation of BMOV in the presence of blood serum proteins†
Abstract
The interaction of the potent anti-diabetic agent bis(maltolato)oxidovanadium(IV) (BMOV) with some
Maintenance work is planned for Wednesday 1st May 2024 from 9:00am to 11:00am (BST).
During this time, the performance of our website may be affected - searches may run slowly and some pages may be temporarily unavailable. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a Istituto CNR di Chimica Biomolecolare, Trav. La Crucca 3, I-07040 Sassari, Italy
b Department of Inorganic and Analytical Chemistry, University of Debrecen, H-4010 Debrecen, Hungary
c
Dipartimento di Chimica and Centro Interdisciplinare per lo Sviluppo della Ricerca Biotecnologica e per lo Studio della Biodiversità della Sardegna, Università di Sassari, Via Vienna 2, I-07100 Sassari, Italy
E-mail:
garribba@uniss.it
Fax: +39 079 212069
Tel: +39 079 229487
The interaction of the potent anti-diabetic agent bis(maltolato)oxidovanadium(IV) (BMOV) with some
Fetching data from CrossRef.
This may take some time to load.
Loading related content